Murakami T, Mizuno S, Takahashi Y, Ohsato K, Moriuchi I, Arai Y, Mifune J, Shimizu M, Ohnaka M
Department of Cardiology, Fukui Cardiovascular Center, Shimbo, Japan.
Am J Cardiol. 1998 Oct 1;82(7):839-44. doi: 10.1016/s0002-9149(98)00489-5.
To investigate the pathogenesis of acute myocardial infarction (AMI) and values of intracoronary aspiration thrombectomy (ICAT), we applied ICAT to reperfusion therapy using generally available intracoronary catheters to aspirate intracoronary occlusive tissues. We assigned ICAT or primary percutaneous transluminal coronary angioplasty (PTCA) to patients with evolving AMI (Thrombolysis In Myocardial Infarction (TIMI) trial grade 0), and investigated primary histopathologic, clinical, and angiographic outcomes in 43 patients treated with ICAT alone or followed by PTCA, and compared the outcomes with those in 48 patients treated with primary PTCA. No major complications (procedural death, emergent bypass graft surgery) occurred. Reconalization (TIMI grade 3 and 2) was achieved in 25 patients (58%) with ICAT alone and in 39 patients (91%) with ICAT alone or followed by PTCA. Aspirated thrombi were defined as recent thrombi in 21 cases (49%), atheroma in 6 (14%), no thrombi in 13 (30%), and organized thrombi in 1 case. In cases of recent thrombi, ICAT alone provided recanalization more frequently than in those of atheroma or no thrombi (18 of 21 [86%], 3 of 6 [50%], 4 of 13 [31%], respectively; p < 0.05; recent thrombi vs atheroma or no thrombi). There were no significant differences in primary recanalization rate (ICAT alone or followed by PTCA vs primary PTCA; 91% vs 92%) or incidence of complications between the 2 strategies. These results indicate that although the pathogenesis of AMI is heterogeneous in each individual case, intracoronary thrombus contributes little to the pathogenesis of average AMI, and therefore mechanical approaches may be feasible to maximize reperfusion therapies for AMI.
为了研究急性心肌梗死(AMI)的发病机制及冠状动脉内血栓抽吸术(ICAT)的价值,我们使用普通的冠状动脉内导管进行ICAT以抽吸冠状动脉内闭塞组织,将其应用于再灌注治疗。我们将ICAT或直接经皮冠状动脉腔内血管成形术(PTCA)应用于进展期AMI患者(心肌梗死溶栓治疗(TIMI)试验0级),并对43例单独接受ICAT治疗或随后接受PTCA治疗的患者的原发性组织病理学、临床和血管造影结果进行了研究,并将结果与48例接受直接PTCA治疗的患者进行了比较。未发生重大并发症(手术死亡、急诊搭桥手术)。单独使用ICAT的25例患者(58%)以及单独使用ICAT或随后接受PTCA治疗的39例患者(91%)实现了再通(TIMI 3级和2级)。抽吸的血栓在21例(49%)中被定义为新鲜血栓,6例(14%)为动脉粥样硬化斑块,13例(30%)无血栓,1例为机化血栓。在新鲜血栓病例中,单独使用ICAT实现再通的频率高于动脉粥样硬化斑块或无血栓病例(分别为21例中的18例[86%]、6例中的3例[50%]、13例中的4例[31%];p<0.05;新鲜血栓与动脉粥样硬化斑块或无血栓相比)。两种策略在原发性再通率(单独使用ICAT或随后接受PTCA与直接PTCA;91%对92%)或并发症发生率方面无显著差异。这些结果表明,尽管AMI的发病机制在每个个体病例中是异质性的,但冠状动脉内血栓对平均AMI发病机制的贡献很小,因此机械方法可能是使AMI再灌注治疗最大化的可行方法。